More Weight Loss Solutions

Lilly To Build 1st Factory in Germany as Demand for Weight-Loss … – Investopedia

Nov 19th, 2023

Key Takeaways

Pharmaceuticals maker Eli Lilly (LLY) is building its first facility in Germany in response to the booming demand for weight-loss drugs.

Lilly reportedly said that it would be spending 2.3 billion euros ($2.5 billion) to construct the high-tech factory in Alzey, Germany. The drug maker noted the plant will further expand its injectable product and device manufacturing network and support an increased demand for Lillys medicines, including its diabetes and obesity portfolio.

Lillys injectable diabetes drug, Mounjaro, has been shown to help patients lose weight, and a second medicine, Zepbound, containing the active ingredient in Mounjaro, last week received Food and Drug Administration approval for use as a weight-loss treatment. That news sent Lilly shares to an all-time high.

With the addition of the Alzey location, Lilly will have six manufacturing sites in Europe. The company said that it has announced $11 billion in investments in its worldwide manufacturing footprint over the past three years, Reuters reported.

Shares of Eli Lilly were up modestly Friday, and have added about two-thirds to their value this year.

See the article here:
Lilly To Build 1st Factory in Germany as Demand for Weight-Loss ... - Investopedia

Related Posts

Contact One Of Our Consultants Today

Your Full Name
Your Email
Your Phone Number
Select your age (30+ only)
Confirm over 30 years old  Yes
Confirm that you are a US Citizen  Yes
This is a Serious Inquiry  Yes
Select A Program
Select Your US State
captcha Please Enter Code:

Comments are closed.
Weight Loss Solutions